Equilibre

New York, United States

Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates.

$6.0M raised

Dec 2022

Venture - Series Unknown

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Equilibre raised?

Equilibre has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.

Who are Equilibre's investors?

Equilibre's investors include Third Point Ventures.

Where is Equilibre headquartered?

Equilibre is headquartered in New York, United States.

What does Equilibre do?

Equilibre is a biopharmaceuticals corporation developing differentiated and novel therapeutic candidates.

What stage is Equilibre at?

Equilibre is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2022.

MLA

"Equilibre — Funding & Investors." VCBacked, December 1, 2022, https://www.vcbacked.co/company/equilibre. Accessed July 2, 2026.

APA

VCBacked. (2022). Equilibre — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/equilibre

Wikipedia (cite web)

{{cite web |title=Equilibre — Funding & Investors |url=https://www.vcbacked.co/company/equilibre |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2022.